Key Highlights

● About 99.6% of votes cast backed the Rocket Lab deal on September 24.

● The deal offers $27 per share in cash plus Rocket Lab stock under a collar.

● Rocket Lab raised $1.94 billion through an at-the-market offering in September.

● The outside date is June 28, 2027, with automatic extensions available.

Iridium Communications (NASDAQ:IRDM) shareholders have cleared a major hurdle in the planned acquisition by Rocket Lab (NASDAQ:RKLB). At a special meeting on September 24, 2026, about 99.6% of votes cast backed the deal, representing roughly 81% of outstanding shares entitled to vote. With the federal antitrust waiting period also reported as lapsed, attention could shift to licence transfers and other approvals. Closing is expected by mid-2027, and conditions remain outstanding, so completion is not assured.

Latest Company Context

The agreement, struck in June 2026, offers Iridium holders $27 per share in cash plus Rocket Lab stock under a collar, for a notional $54 per share and a transaction value of roughly $8 billion. Rocket Lab's registration statement has been filed, and applications to transfer Iridium's licences were filed with the FCC. Rocket Lab raised $1.94 billion through an at-the-market equity offering in September, issuing 29.3 million shares to fund the cash portion, terminated its $3.6 billion bridge facility, and Iridium amended its term loan to carve out the acquisition from change-of-control provisions. Rocket Lab's proxy and prospectus describe an outside date of June 28, 2027, with automatic three-month extensions to September and December 2027 where only regulatory matters remain.

Key Business Drivers

With the vote and antitrust steps behind it, the remaining timeline depends on regulatory approvals, including FCC licence transfers and any required foreign clearances, plus customary conditions. The filing says Rocket Lab's obligations are not conditioned on financing or on its own stockholder vote. Iridium would owe Rocket Lab a $223.62 million termination fee in specified circumstances. The collar means the stock component floats between a fixed ratio of 0.4000 at or below a $67.50 Rocket Lab price and 0.2400 at or above $112.50, so Rocket Lab's share price during the pricing window could affect what Iridium holders receive. Iridium's own results continue to be reported separately during the pending period, and the combined company's leverage would depend on final financing choices that remain subject to market conditions.

What Investors Should Watch

Observers could track FCC action on the licence transfer applications and any announcement of foreign approvals. They might also follow Rocket Lab's share price, given the collar, and any further financing steps, such as debt for the remainder of the cash requirement. Iridium's third-quarter results, could show whether standalone operations remain steady during the pending period. Any change to the expected mid-2027 closing, or use of the extension periods, would be a notable signal. Conditions in the merger agreement could also change the terms if circumstances shift. Shareholders might also review how Rocket Lab describes integration plans and any commentary on Iridium's government and aviation customers.

Collar Mechanics and Licences Decide Iridium's Final Price

Iridium's shareholder vote and the lapse of the antitrust period remove two uncertainties, and financing steps at Rocket Lab appear to have advanced. Regulatory approvals and the collar mechanics remain the open items, and a closing target as late as mid-2027 leaves a long interval in which conditions may change. The deal values quoted use Rocket Lab's share price at stated dates and will move as markets move, so the headline figure of $54 is notional rather than fixed.